Navigation Links
American Chemistry Council Welcomes Call for Expedited FDA Review of BPA

The following statement can be attributed to the American Chemistry Council (ACC):

ARLINGTON, Va., June 2 /PRNewswire-USNewswire/ -- The American Chemistry Council (ACC) today welcomed a congressional request to the Food and Drug Administration (FDA) to expedite its review of the scientific evidence on the safety of bisphenol A (BPA) in food-contact products.

We agree with Reps. Henry Waxman and Bart Stupak that an immediate, transparent assessment of the science, including all relevant data and scientific studies, is welcome and in the public's best interest. ACC and its member companies rely on and will respect FDA's guidance on the safety of food-contact products containing BPA as they have consistently done in response to all prior FDA findings on BPA safety. Timely decisions, based on science, will give the public the confidence it deserves in the safety of these products.

Within the last year, the European Union, European Food Safety Authority, German Federal Institute for Risk Assessment, Danish Environmental Protection Agency, French Food Safety Authority, Swiss Office for Public Health, and others have extensively evaluated the science around BPA and uniformly concluded that BPA is safe in food-contact products. We look forward to FDA's similarly thorough and science-based review.

Through our scientific research and communications, the ACC is working hard to develop and communicate accurate information about the safety profile of BPA and the benefits it provides to consumers. Clear and shatter-resistant polycarbonate plastic, made from BPA, is used to make products ranging from eyeglass lenses and bicycle helmets to DVDs and food storage containers. Epoxy resins, also made from BPA, are widely used to line food and beverage cans to prevent corrosion, contamination and food spoilage.

The American Chemistry Council (ACC) represents the leading companies engaged in the business of chemistry. ACC members apply the science of chemistry to make innovative products and services that make people's lives better, healthier and safer. ACC is committed to improved environmental, health and safety performance through Responsible Care(R), common sense advocacy designed to address major public policy issues, and health and environmental research and product testing. The business of chemistry is a $664 billion enterprise and a key element of the nation's economy. It is one of the nation's largest exporters, accounting for ten cents out of every dollar in U.S. exports. Chemistry companies are among the largest investors in research and development. Safety and security have always been primary concerns of ACC members, and they have intensified their efforts, working closely with government agencies to improve security and to defend against any threat to the nation's critical infrastructure.

SOURCE American Chemistry Council
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Upcoming Investor Events at The American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Exposition
2. Darwins Kim Lloyd to Speak on Panel at American Hospital Association Solutions Roundtable, June 3, 2009
3. American Red Cross Set to Collect Blood from 16-Year Olds with Parental Consent
4. Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations
5. American Medical Buildings Completes New Ambulatory Care Center for Beverly Hospital
6. Clinical Utility of Exhaled Nitric Oxide Highlighted By American Thoracic Society Panel
7. iMedica Participates in American College of Physicians EHR Partners Program
8. Arizona American Water and Salvation Army Offer Aid on Hottest Days
9. Senators Arlen Specter and John Cornyn Will Discuss Medicare Issues at American Association for Homecare Legislative Conference, June 2-3, 2009
10. AT&T Shares 2009 NCAA Womens College World Series With American Cancer Society and Boys & Girls Club
11. Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators (ACATA)
Post Your Comments:
(Date:11/27/2015)... Denver, CO (PRWEB) , ... November 27, 2015 , ... ... U.S. cities are not changing the way that they are handling security in light ... increasing police and security presence in an attempt to stop an attack from reaching ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse and ... findings on the website. Click here to read the details now. ... were treated with chemotherapy followed by EPP surgery. Among the 106 patients who relapsed, ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was traveling, I ... Hillside, N.J. "Many people catch diseases simply from sitting on such dirty toilet ... protected from germs." , He developed the patent-pending QUDRATECS to eliminate the need ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print ... USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation ... is distributed nationally, through a vast social media strategy and across a network ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, ... Table 1-1 ). More than 3.7 billion people under the age of 50 – ... according to WHO's first global estimates of HSV-1 infection . , "The data shocks ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... "Self Administration of High Viscosity Drugs" report ... has announced the addition of the "Self ... their offering. --> Research and Markets ... the "Self Administration of High Viscosity Drugs" ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Marker Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
Breaking Medicine Technology: